• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低人类免疫缺陷病毒1型载量及抗逆转录病毒治疗对IgG捕获BED酶免疫测定法的影响

Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay.

作者信息

Hayashida Tsunefusa, Gatanaga Hiroyuki, Tanuma Junko, Oka Shinichi

机构信息

AIDS Clinical Center, International Medical Center of Japan, Tokyo, Japan.

出版信息

AIDS Res Hum Retroviruses. 2008 Mar;24(3):495-8. doi: 10.1089/aid.2007.0150.

DOI:10.1089/aid.2007.0150
PMID:18327979
Abstract

The IgG-capture BED-enzyme immunoassay (BED-CEIA) is used widely at present to detect recent HIV-1 seroconversion. However, antibody levels and antibody kinetics are impacted by HIV-1 load and antiretroviral treatment, which may have a significant effect on the assay results. In this study, we analyzed serial samples from 11 patients with recent infection, including four patients treated by structured treatment interruption (STI), and compared the results with those of 10 untreated and 7 treated patients with chronic infection. The BED-CEIA missidentified one long-term nonprogressor hemophiliac with an extremely low HIV-1 load and five patients with chronic infection who received antiretroviral treatment. We also found that the ODn values increased slowly in patients with recent infection and low HIV-1 loads and that the ODn values fluctuated in parallel with HIV-1 load during STI. Our data indicate that the results of BED-CEIA are influenced by HIV-1 load and antiretroviral treatment. Care should be taken when interpreting the results of BED-CEIA, especially in individuals with low HIV-1 loads. Those on antiretroviral treatment should be excluded from BED-CEIA testing to improve the predictive value of detecting recent infections.

摘要

目前,IgG捕获BED酶免疫测定法(BED-CEIA)被广泛用于检测近期HIV-1血清转化。然而,抗体水平和抗体动力学受HIV-1载量和抗逆转录病毒治疗的影响,这可能对检测结果产生显著影响。在本研究中,我们分析了11例近期感染患者的系列样本,其中包括4例接受结构化治疗中断(STI)的患者,并将结果与10例未治疗的慢性感染患者和7例接受治疗的慢性感染患者的结果进行比较。BED-CEIA将1例HIV-1载量极低的长期不进展血友病患者以及5例接受抗逆转录病毒治疗的慢性感染患者误判。我们还发现,近期感染且HIV-1载量低的患者ODn值上升缓慢,且在STI期间ODn值随HIV-1载量平行波动。我们的数据表明,BED-CEIA的结果受HIV-1载量和抗逆转录病毒治疗的影响。在解释BED-CEIA结果时应谨慎,尤其是对于HIV-1载量低的个体。接受抗逆转录病毒治疗的患者应排除在BED-CEIA检测之外,以提高检测近期感染的预测价值。

相似文献

1
Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay.低人类免疫缺陷病毒1型载量及抗逆转录病毒治疗对IgG捕获BED酶免疫测定法的影响
AIDS Res Hum Retroviruses. 2008 Mar;24(3):495-8. doi: 10.1089/aid.2007.0150.
2
Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.使用BED捕获免疫测定法与近期HIV感染错误识别相关的因素。
AIDS Res Hum Retroviruses. 2012 Aug;28(8):816-22. doi: 10.1089/aid.2011.0258. Epub 2011 Dec 1.
3
Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.在 CD4 计数非常低的 HIV-1 患者和接受抗逆转录病毒治疗的患者中,BED 捕获酶免疫测定的长期特异性显著降低。
J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):496-9. doi: 10.1097/qai.0b013e3181b61938.
4
Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.自然和 ARV 诱导的病毒抑制及病毒突破对 HIV-1 亚型 B 感染患者抗 HIV 抗体比例和亲和力的影响。
PLoS One. 2013;8(2):e55525. doi: 10.1371/journal.pone.0055525. Epub 2013 Feb 20.
5
Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion.免疫球蛋白G捕获BED-酶免疫测定法的性能特征,一种用于检测近期1型人类免疫缺陷病毒血清转换的测定法。
J Clin Microbiol. 2004 Jun;42(6):2623-8. doi: 10.1128/JCM.42.6.2623-2628.2004.
6
Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007.2006-2007 年在中国开远市,应用 BED 捕获酶免疫测定法估计女性性工作者中的 HIV 感染率。
Int J Infect Dis. 2010 Jul;14(7):e608-12. doi: 10.1016/j.ijid.2009.09.004. Epub 2010 Jan 25.
7
Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.运用BED捕获酶免疫测定法确定感染多种亚型的人群中1型人类免疫缺陷病毒发病率估计的平均近期感染期
AIDS Res Hum Retroviruses. 2011 Mar;27(3):265-73. doi: 10.1089/aid.2010.0159. Epub 2010 Oct 18.
8
Temporal trends in HIV Type 1 incidence among inner-city childbearing women in Atlanta: use of the IgG-capture BED-enzyme immunoassay.亚特兰大市中心育龄妇女中1型人类免疫缺陷病毒发病率的时间趋势:IgG捕获BED酶免疫测定法的应用
AIDS Res Hum Retroviruses. 2005 Jun;21(6):537-44. doi: 10.1089/aid.2005.21.537.
9
Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.越南极限抗原亲和力酶免疫测定法和BED捕获酶免疫测定法的假近期分类估计:对HIV-1发病率估计的影响
AIDS Res Hum Retroviruses. 2017 Jun;33(6):546-554. doi: 10.1089/AID.2016.0203. Epub 2017 Mar 13.
10
HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay.通过对曼谷注射吸毒者横断面抽样检测近期感染情况来估计1型艾滋病毒发病率:使用IgG捕获BED酶免疫测定法。
AIDS Res Hum Retroviruses. 2003 Sep;19(9):727-30. doi: 10.1089/088922203769232511.

引用本文的文献

1
Recent HIV Infection: Diagnosis and Public Health Implications.近期HIV感染:诊断及对公共卫生的影响
Diagnostics (Basel). 2022 Nov 1;12(11):2657. doi: 10.3390/diagnostics12112657.
2
Validation of mailed postal service dried blood spot cards on commercially available HIV testing systems.市售HIV检测系统上邮寄的邮政服务干血斑卡片的验证
Glob Health Med. 2021 Dec 31;3(6):394-400. doi: 10.35772/ghm.2021.01105.
3
Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.
通过 HPTN 071(PopART)试验中的横断面发病率检测对人群 HIV-1 发病率估计进行验证。
J Int AIDS Soc. 2021 Dec;24(12):e25830. doi: 10.1002/jia2.25830.
4
A top scoring pairs classifier for recent HIV infections.用于近期 HIV 感染的高分对分类器。
Stat Med. 2021 May 20;40(11):2604-2612. doi: 10.1002/sim.8920. Epub 2021 Mar 3.
5
Diagnosis of Human Immunodeficiency Virus Infection.人类免疫缺陷病毒感染的诊断。
Clin Microbiol Rev. 2018 Nov 28;32(1). doi: 10.1128/CMR.00064-18. Print 2019 Jan.
6
Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial.自我报告与近期 HIV 感染生物标志物的比较:来自 START 试验的结果。
AIDS Behav. 2018 Jul;22(7):2277-2283. doi: 10.1007/s10461-018-2048-y.
7
Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.巴西北部地区HIV-1病毒血症控制者的免疫学和病毒学特征
BMC Infect Dis. 2017 Jun 1;17(1):381. doi: 10.1186/s12879-017-2491-9.
8
Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.越南极限抗原亲和力酶免疫测定法和BED捕获酶免疫测定法的假近期分类估计:对HIV-1发病率估计的影响
AIDS Res Hum Retroviruses. 2017 Jun;33(6):546-554. doi: 10.1089/AID.2016.0203. Epub 2017 Mar 13.
9
Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.用于估计B亚型人群横断面发病率的改良第四代人类免疫缺陷病毒酶免疫测定法的开发与评估
AIDS Res Hum Retroviruses. 2016 Aug;32(8):756-62. doi: 10.1089/AID.2015.0198. Epub 2016 May 5.
10
HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles.具有不同病毒载量截断水平的HIV控制者具有不同的病毒学和免疫学特征。
J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):377-385. doi: 10.1097/QAI.0000000000000500.